Joe Biden's recent initiative challenges Big Pharma.
The administration’s new push to use march-in rights could eventually have major ramifications for the pharmaceutical industry, which has long argued that the policy discourages research and development of new drugs.
https://www.cnbc.com/2023/12/07/biden-administration-asserts-power-to-seize-drug-patents.html
There are no comments yet.